Literature DB >> 33687545

Impact of the size of non-ablated left atrial posterior wall area on outcomes after extensive encircling pulmonary vein isolation.

Shingo Yoshimura1, Kenichi Kaseno2, Kohki Kimura2, Wataru Sasaki2, Yoshinori Okazaki2, Yumiko Haraguchi2, Shohei Kishi2, Takehito Sasaki2, Koji Goto2, Yuko Miki2, Yutaka Take2, Kohki Nakamura2, Shigeto Naito2.   

Abstract

The aim of this study was to evaluate the impact of the size of the isolated surface area and non-ablated left atrial posterior area after extensive encircling pulmonary vein isolation (EEPVI) for non-paroxysmal atrial fibrillation (AF) on arrhythmia recurrence. This study included 132 consecutive persistent AF patients who underwent EEPVI guided by Ablation Index (AI). The isolated antral surface area (IASA) excluding the pulmonary veins, the non-ablated left atrial (LA) posterior wall surface area (PWSA), the ratio of IASA to LA surface area (IASA/LA ratio), and the ratio of PWSA to LA surface area (PWSA/LA ratio) were assessed using CARTO3 and the association with AF and atrial tachycardia (AT) recurrence was examined. At a mean follow-up of 13.2 ± 7.3 months, sinus rhythm was maintained in 115 (87%) patients. In the univariate Cox regression analysis, the factors that significantly predicted AT/AF recurrence were a history of heart failure, a higher CHA2DS2-VASc score, a larger LA diameter, and a larger PWSA/LA ratio. Multivariate Cox regression analysis revealed that the independent predictors of AT/AF recurrence were LA diameter [hazard ratio (HR) 1.120 per 1 mm increase; 95% confidence interval (CI) 1.006-1.247; P = 0.039] and PWSA/LA ratio (HR 1.218 per 1% increase; 95% CI 1.041-1.425; P = 0.014). Receiver operating characteristics curve analysis yielded an optimal cut-off value of 8% for the PWSA/LA ratio. The Kaplan-Meier survival curve showed that patients with a larger PWSA/LA ratio had poorer clinical outcomes (Log-rank P = 0.001). A larger PWSA/LA ratio was associated with a high AT/AF recurrence rate in patients with non-paroxysmal atrial fibrillation.
© 2021. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Isolation area; Pulmonary vein isolation

Mesh:

Year:  2021        PMID: 33687545     DOI: 10.1007/s00380-021-01820-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  2 in total

1.  Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry.

Authors:  Kazuki Iso; Koichi Nagashima; Masaru Arai; Ryuta Watanabe; Katsuaki Yokoyama; Naoya Matsumoto; Takayuki Otsuka; Shinya Suzuki; Akio Hirata; Masato Murakami; Mitsuru Takami; Masaomi Kimura; Hidehira Fukaya; Shiro Nakahara; Takeshi Kato; Hiroshi Hayashi; Yu-Ki Iwasaki; Wataru Shimizu; Ikutaro Nakajima; Tomoo Harada; Junjiroh Koyama; Ken Okumura; Michifumi Tokuda; Teiichi Yamane; Kojiro Tanimoto; Yukihiko Momiyama; Noriko Nonoguchi; Kyoko Soejima; Koichiro Ejima; Nobuhisa Hagiwara; Masahide Harada; Kazumasa Sonoda; Masaru Inoue; Koji Kumagai; Hidemori Hayashi; Yoshinao Yazaki; Kazuhiro Satomi; Yuji Watari; Yasuo Okumura
Journal:  Heart Vessels       Date:  2020-11-24       Impact factor: 2.037

2.  Ablation index, a novel marker of ablation lesion quality: prediction of pulmonary vein reconnection at repeat electrophysiology study and regional differences in target values.

Authors:  Moloy Das; Jonathan J Loveday; Gareth J Wynn; Sean Gomes; Yawer Saeed; Laura J Bonnett; Johan E P Waktare; Derick M Todd; Mark C S Hall; Richard L Snowdon; Simon Modi; Dhiraj Gupta
Journal:  Europace       Date:  2017-05-01       Impact factor: 5.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.